Glynis Ablon, MD: Winter Clinical Presentation on Evaluating the Aesthetic Patient

Video

In her latest HCPLive interview, Ablon discusses her Winter Clinical Miami dermatology conference presentation ‘Evaluating the Aesthetic Patient’ and its biggest takeaways.

During her recent HCPLive interview, Glynis Ablon, MD, discussed several highlights from her recent presentation ‘Evaluating the Aesthetic Patient’ from the 2023 Winter Clinical Miami dermatology conference.

Ablon is known for her work as both an associate clinical professor at UCLA as well as for being the founder of the Ablon Skin Institute & Research Center in Manhattan Beach, California.

Ablon first described her background in the field, then getting into the steps she believes are needed to evaluate patients coming into one’s practice for aesthetic procedures.

“I think the biggest thing to understand is there are two steps to evaluating the aesthetic patient,” she explained. “The first one is to really get to know the patient themselves, and develop basically their emotional levels and, and stability. So you really want to make sure when you're dealing with an aesthetic patient, that you have someone that is emotionally stable, there can be variations on that.”

During an aesthetic consultation, Ablon explained that the nurse will typically give the basic information on a patient’s expectations.

“And step 2 becomes the actual physical evaluation,” she further explained. “...So we're talking about the skin and the skin changes, then the fat pads followed by the muscle and then the boat. And then the second step that I like to discuss is the morphology and those morphologic changes that occur with the aesthetic face.”

Ablon continued her description of the consultation process, explaining the way clinicians should help patients come to the right conclusions.

“Finally, I like to look at symmetry, which of course does get worse with age,” she said. “...I think that especially, having been doing this for 27 years, you understand that if you can deal with patients that are realistic, you're going to have very happy patients.”

Ablon added that patients with unrealistic expectations or desires to look completely different may require their physician to lead them away from these conclusions or tell them no.

To learn more about Ablon’s Winter Clinical Miami conference presentation, view the interview listed above.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.